ArticleiScience2023

Transcriptomic and proteomic assessment of tocilizumab response in a randomized controlled trial of patients hospitalized with COVID-19.

Haridha Shivram et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.